BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 708K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now
Advanced Search

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

8 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Heterocyclic compounds and uses thereofBDB
Infinity Pharmaceuticals
An Overview of Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy.BDB
University of Bonn
Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseasesBDB
Galderma Research & Development
Discovery of novel 2-substituted-4-(2-fluorophenoxy) pyridine derivatives possessing pyrazolone and triazole moieties as dual c-Met/VEGFR-2 receptor tyrosine kinase inhibitorsBDB
China Pharmaceutical University
6-thio-substituted imidazo[1,2-a]pyrazines as Mps-1 inhibitorsBDB
Bayer Intellectual Property
Substituted pyrimidine compounds and their use as SYK inhibitorsBDB
Genosco
Heterocyclic carboxamides as modulators of kinase activityBDB
Merck Patent
Structure-based design of potent and selective cell-permeable inhibitors of human beta-secretase (BACE-1).BDB
Merck Research Laboratories